Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 1

Status

Active not recruiting 4Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Hypoxia 2Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × fluoroazomycin arabinoside × 1 year × Clear all
NCT01549730 2026-04-29

Cervix Hypoxia FAZA

University Health Network, Toronto

Phase NA Active not recruiting
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
25 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms

NCT01567800 2026-03-06

Prostate Hypoxia FAZA

University Health Network, Toronto

Phase NA Completed
18 enrolled
Genitourinary

Prostatic Neoplasms

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting
70 enrolled
Sarcoma

Hypoxia, Sarcoma

NCT04395469 2026-03-05

FAZA PET/MRI Pancreas

University Health Network, Toronto

Phase NA Active not recruiting
20 enrolled

Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡